The authors evaluated the efficacy of Quinax in 4 groups of patients with cataract. An observation of--on the average--5 years duration showed that systematic application of the drug prevents the development of the early senile cataract and distinctly slows down the progress of the disease in the group of patients without the risk factors. Non systematic application of the compound also slows down the progress of the condition in the group of early cataract. The drug was ineffective in patients with an advanced diabetic cataract.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
systematic application
8
slows progress
8
[evaluation effectiveness
4
effectiveness quinax
4
quinax prevention
4
prevention development
4
development senile
4
senile cataract]
4
cataract] authors
4
authors evaluated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!